Items where authors include "Baker, H."

Article

Ettehad, D., Mohammed, H., Bailey, J.V. et al. (11 more authors) (2025) Barriers and facilitators to prostate cancer healthcare in Black men in the UK: from diagnosis to survivorship. Journal of Cancer Survivorship. ISSN 1932-2259

Stevenson, M. orcid.org/0000-0002-3099-9877, Forsyth, J.E., Hossain, A. et al. (525 more authors) (2025) Cost-effectiveness of procalcitonin-guided antibiotic duration for hospitalized patients with sepsis. Critical Care, 29 (1). 508. ISSN 1364-8535

Dark, P., Hossain, A., McAuley, D.F. et al. (543 more authors) (2025) Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. Journal of the American Medical Association (JAMA), 333 (8). pp. 682-693. ISSN 0098-7484

Chapman, S.J. orcid.org/0000-0003-2413-5690, Burke, J.R., Helliwell, J. et al. (300 more authors) (2024) Management of subcutaneous abscesses: prospective cross-sectional study (MAGIC). British Journal of Surgery, 111 (8). znae162. ISSN 0007-1323

Brede, J. orcid.org/0000-0001-7359-9112, Babb, C., Jones, C.R.G. et al. (6 more authors) (2024) The clinical characteristics of autistic women with restrictive eating disorders. BJPsych Open, 10 (4). e131. ISSN 2056-4724

Goodyear, C.S., Patel, A., Barnes, E. et al. (118 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Goodyear, C.S., Patel, A., Barnes, E. et al. (119 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Munro, A.P.S., Feng, S., Janani, L. et al. (362 more authors) (2022) Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. The Lancet Infectious Diseases, 22 (8). pp. 1131-1141. ISSN 1473-3099

Khetrapal, P., Stafford, R., Ó Scanaill, P. et al. (15 more authors) (2022) Measuring patient compliance with remote monitoring following discharge from hospital after major surgery (DREAMPath): protocol for a prospective observational study. JMIR Research Protocols, 11 (4). e30638. ISSN 1929-0748